Study of the Broad Clinical Benefit for Seroquel XR With Flexible Dose as an add-on Therapy in the Treatment of Acute Bipolar Mania Patients With Partial Response to Current Therapy

NCT01128114 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

32

Enrollment

INDUSTRY

Sponsor class

Stopped Poor recruitment

Conditions

Acute Bipolar Mania

Interventions

DRUG: Quetiapine fumarate (Seroquel XR)

Sponsor

AstraZeneca